https://doi.org/10.4081/monaldi.2022.2418
Pulmonary embolism and gastric bleed with disseminated mucormycosis - treading dangerous waters
Submitted: August 30, 2022
Accepted: October 28, 2022
Published: November 25, 2022
Accepted: October 28, 2022
Abstract Views: 908
PDF: 143
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
Mucormycosis is an opportunistic infection seen in immunocompromised patients or in surgical and trauma settings with Mucorales wound contamination. In immunocompetent people, disseminated mucormycosis is uncommon. To ensure survival, patients with mucormycosis require early diagnosis and aggressive treatment using a multi-modality approach. We present a case of disseminated mucormycosis in an immunocompetent patient who also had pulmonary embolism and gastrointestinal bleeding. A recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, identified retrospectively by a positive IgM against SARS-CoV-2, was the only risk factor present. This report emphasizes the increased risk of mucormycosis and thromboembolic complications following a recent SARS-CoV-2 infection, as well as its successful treatment with medical therapy alone.
Spellberg B, Edwards Jr J, Ibrahim A. Novel perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev 2005;18:556-69.
DOI: https://doi.org/10.1128/CMR.18.3.556-569.2005
Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: A Review of 929 reported cases. Clin Infect Dis 2005;1:634-53.
DOI: https://doi.org/10.1086/432579
Raut A, Huy NT. Rising incidence of mucormycosis in patients with COVID-19: another challenge for India amidst the second wave? Lancet Respir Med 2021;9:e77.
DOI: https://doi.org/10.1016/S2213-2600(21)00265-4
Singh AK, Singh R, Joshi SR, Misra A. Mucormycosis in COVID- 19: a systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021;15:102146.
DOI: https://doi.org/10.1016/j.dsx.2021.05.019
Tan BK, Mainbourg S, Friggeri A, et al. Arterial and venous thromboembolism in COVID-19: a study-level meta-analysis. Thorax 2021;76:970-9.
DOI: https://doi.org/10.1136/thoraxjnl-2020-215383
Jacofsky D, Jacofsky EM, Jacofsky M. Understanding antibody testing for COVID-19. J Arthroplasty 2020;35:S74-S81.
DOI: https://doi.org/10.1016/j.arth.2020.04.055
Maraví-Poma E, Rodríguez-Tudela JL, de Jalón JG, et al. Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients. Intensive Care Med 2004;30:724-8.
DOI: https://doi.org/10.1007/s00134-003-2132-1
Pak J, Tucci VT, Vincent AL, et al. Mucormycosis in immunochallenged patients. J Emerg Trauma Shock 2008;1:106-13.
DOI: https://doi.org/10.4103/0974-2700.42203
Skiada A, Lass-Floerl C, Klimko N, et al. Challenges in the diagnosis and treatment of mucormycosis. Med Mycol 20181;56:93-101.
DOI: https://doi.org/10.1093/mmy/myx101
Naqvi HA, Nadeem Yousaf M, Chaudhary FS, Mills L. Gastric mucormycosis: An infection of fungal invasion into the gastric mucosa in immunocompromised patients. Case Rep Gastrointest Med 2020;16:8876125.
DOI: https://doi.org/10.1155/2020/8876125
Chikley A, Ben-Ami R, Kontoyiannis DP. Mucormycosis of the central nervous system. J Fungi 2019;8:59.
DOI: https://doi.org/10.3390/jof5030059
Mignogna MD, Fortuna G, Leuci S, et al. Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature. Int J Infect Dis 2011;15:533-40.
DOI: https://doi.org/10.1016/j.ijid.2011.02.005
Nain PS, Matta H, Singh K, et al. Post-operative abdominal wall mucormycosis - a case series. Indian J Surg 2015;77:S253-6.
DOI: https://doi.org/10.1007/s12262-012-0786-z
How to Cite
Chauhan, Nishant Kumar, Ashish Agarwal, Naveen Dutt, Taruna Yadav, and Rishabh Kochar. 2022. “Pulmonary Embolism and Gastric Bleed With Disseminated Mucormycosis - Treading Dangerous Waters”. Monaldi Archives for Chest Disease 93 (3). https://doi.org/10.4081/monaldi.2022.2418.
Copyright (c) 2022 The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- Umberto Caterino, Dario Amore , Maria Chiara Petagna, Dino Casazza, Roberto Marchese, Emergency rigid bronchoscopy in two lower social class patients with mirror like complete pulmonary malignant atelectasis , Monaldi Archives for Chest Disease: Vol. 91 No. 2 (2021)
- Gian Francesco Mureddu, Pompilio Faggiano, Francesco Fattirolli, Preoperative evaluation before non cardiac surgery in subjects older than 65 years , Monaldi Archives for Chest Disease: Vol. 82 No. 1 (2014): Cardiac series
- Bruno Sposato, Significant gas-exchange improvements reported after roflumilast in two cases of severe COPD , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
- Biagio Polla, Roflumilast is effective in reducing COPD related exacerbations and improving CAT score , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
- Sandeep Gupta, Ashlesha Kaushik, Jitendra Gupta, Management and outcomes of patients hospitalized with severe COVID-19 at a tertiary care center in midwestern United States , Monaldi Archives for Chest Disease: Vol. 90 No. 4 (2020)
- Daniela Parola, Ambra Castagnacci, Sara Salvati, A case report of roflumilast in an elderly COPD patient: improving exercise capacity to improve quality of life , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
- Gabriella Guarnieri, Roflumilast succeeds where traditional therapy fails: a case report , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
- Chiara Francesca Carraro, Two cases of COPD benefitting from therapy with roflumilast , Monaldi Archives for Chest Disease: Vol. 79 No. 3-4 (2013): Pulmonary series - Supplement 1
- Ivano Bonadei, Enrico Vizzardi, Antonio D’Aloia, Edoardo Sciatti, Edoardo Cervi, Stefano Bonardelli, Marco Metra, Stefano Maria Giulini, A drastic complex atheromatous aorta A case report , Monaldi Archives for Chest Disease: Vol. 80 No. 1 (2013): Cardiac series
- F. Nicosia, L. Giordano, L. Bonini, L. Corda, M. Bolzon, M. Bettinzoli, A. Braghini, P. Accorsi, C. Tantucci, Hyperventilation and seizures in an adolescent female , Monaldi Archives for Chest Disease: Vol. 79 No. 2 (2013): Pulmonary series
<< < 57 58 59 60 61 62 63 64 65 66 > >>
You may also start an advanced similarity search for this article.
